Optimal control of the chemotherapy of HIV
From MaRDI portal
Publication:1365081
DOI10.1007/S002850050076zbMath0876.92016OpenAlexW2033593383WikidataQ52258657 ScholiaQ52258657MaRDI QIDQ1365081
Denise E. Kirschner, Suzanne M. Lenhart, Steven M. Serbin
Publication date: 25 November 1997
Published in: Journal of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s002850050076
Application models in control theory (93C95) Medical applications (general) (92C50) Control/observation systems governed by ordinary differential equations (93C15)
Related Items (only showing first 100 items - show all)
FEEDBACK CONTROL OF THE CHEMOTHERAPY OF HIV ⋮ Short and long period optimization of drug doses in the treatment of AIDS ⋮ Sparse Optimal Control of Pattern Formations for an SIR Reaction-Diffusion Epidemic Model ⋮ Costs versus benefits: best possible and best practical treatment regimens for HIV ⋮ The cost-effectiveness analysis and optimal strategy of the tobacco control ⋮ Optimal control of combined antiretroviral therapies in an HIV infection model with cure rate and fusion effect ⋮ Stabilization of HIV/AIDS model by receding horizon control ⋮ SATURATION EFFECTS FOR CTL MEDIATED CONTROL OF HIV-1 INFECTION: A MATHEMATICAL STUDY ⋮ Dynamics of a stochastic SICA epidemic model for HIV transmission with higher-order perturbation ⋮ OPTIMAL CONTROL ON RELIABILITY PROBLEMS ⋮ Robust H∞ observer-based tracking control of stochastic immune systems under environmental disturbances and measurement noises ⋮ Immune therapeutic strategies using optimal controls with \(L^{1}\) and \(L^{2}\) type objectives ⋮ Mathematical analysis of the role of HIV/HBV latency in hepatocytes ⋮ Modeling transmission dynamics of Ebola virus disease ⋮ Mathematical modelling of HIV-1 transcription inhibition: a comparative study between optimal control and impulsive approach ⋮ Optimal control strategies for an age‐structured SEIR epidemic model ⋮ A stochastic HIV/HTLV-I co-infection model incorporating the AIDS-related cancer cells ⋮ Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting ⋮ Behavior of trajectories of a four-dimensional model of HIV infection ⋮ Optimal and sub-optimal quarantine and isolation control in SARS epidemics ⋮ Role of optimal screening and treatment on infectious diseases dynamics in presence of self-protection of susceptible ⋮ Optimal Control Analysis of Fascioliasis Disease Transmission Dynamics ⋮ Optimal Control for a SIR Epidemic Model with Nonlinear Incidence Rate ⋮ An age-structured model with immune response of HIV infection: modeling and optimal control approach ⋮ Stability of a delayed SARS-CoV-2 reactivation model with logistic growth and adaptive immune response ⋮ Unnamed Item ⋮ Unnamed Item ⋮ MODELING ZIKA TRANSMISSION DYNAMICS: PREVENTION AND CONTROL ⋮ Optimal control of chemotherapy of HIV model using the coupled Adomian/Alienor methods ⋮ OPTIMAL DOSING STRATEGIES AGAINST SUSCEPTIBLE AND RESISTANT BACTERIA ⋮ Optimal control of innate immune response ⋮ AVIAN INFLUENZA OPTIMAL SEASONAL VACCINATION STRATEGY ⋮ Control of the medical treatment of AIDS ⋮ REVIEW OF HIV MODELS: THE ROLE OF THE NATURAL IMMUNE RESPONSE AND IMPLICATIONS FOR TREATMENT ⋮ Optimal control of a delayed smoking model with immigration ⋮ TRANSMISSION DYNAMICS AND OPTIMAL CONTROL OF AN INFLUENZA MODEL WITH QUARANTINE AND TREATMENT ⋮ The role of asymptomatic class, quarantine and isolation in the transmission of COVID-19 ⋮ Optimal strategy for controlling the spread of HIV/AIDS disease: a case study of South Africa ⋮ Optimal trajectories for angular systems on the projective line ⋮ Treatment Monitoring of HIV‐Infected Patients based on Mechanistic Models ⋮ Optimal control of treatment in a mathematical model of chronic myelogenous leukemia ⋮ Nonautonomous Dynamical Systems in the Life Sciences ⋮ Comparison of optimal controls for a model in cancer chemotherapy withL1- andL2-type objectives ⋮ Genetic Instability in Cancer: An Optimal Control Problem ⋮ A parameter sensitivity methodology in the context of HIV delay equation models ⋮ Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection ⋮ Optimal control and infectiology: Application to an HIV/AIDS model ⋮ Optimal control strategy of HIV-1 epidemic model for recombinant virus ⋮ Mathematical analysis of an influenza epidemic model, formulation of different controlling strategies using optimal control and estimation of basic reproduction number ⋮ Optimal control for a tuberculosis model with undetected cases in Cameroon ⋮ A theoretical study on schistosomiasis infection model: application of biological optimal control ⋮ Optimal drug therapy in a multi-pathways HIV-1 infection model with immune response delay ⋮ Stability and optimal control for an age-structured model of periodical cicadas ⋮ MPC without terminal ingredients tailored to the SEIR compartmental epidemic model ⋮ Optimal control of vaccination for an epidemic model with standard incidence rate ⋮ Optimal Control Measures for Tuberculosis in a Population Affected with Insurgency ⋮ ANALYSIS OF A CELL-CYCLE SPECIFIC MODEL FOR CANCER CHEMOTHERAPY ⋮ THE IMPACT OF THE CD8+ CELL NON-CYTOTOXIC ANTIVIRAL RESPONSE (CNAR) AND CYTOTOXIC T LYMPHOCYTE (CTL) ACTIVITY IN A CELL-TO-CELL SPREAD MODEL FOR HIV-1 WITH A TIME DELAY ⋮ Unnamed Item ⋮ HIV dynamics: Modeling, data analysis, and optimal treatment protocols ⋮ Receding Horizon Control of HIV ⋮ OPTIMAL CONTROL ANALYSIS OF A HUMAN–BOVINE SCHISTOSOMIASIS MODEL ⋮ DYNAMICS OF AN INFECTIOUS DISEASE IN THE PRESENCE OF SATURATED MEDICAL TREATMENT OF HOLLING TYPE III AND SELF-PROTECTION ⋮ Periodically varying antiviral therapies: conditions for global stability of the virus free state ⋮ Unnamed Item ⋮ Optimal control in a multi-pathways HIV-1 infection model: a comparison between mono-drug and multi-drug therapies ⋮ Free terminal time optimal control problem of an HIV model based on a conjugate gradient method ⋮ Incorporation of variability into the modeling of viral delays in HIV infection dynamics ⋮ Malaria and COVID-19 co-dynamics: a mathematical model and optimal control ⋮ Chaotic dynamics of a fractional order HIV-1 model involving AIDS-related cancer cells ⋮ Robust set-point regulation for ecological models with multiple management goals ⋮ Mathematical modeling and numerical simulation of HIV infection model ⋮ Optimal control strategy for prevention of avian influenza pandemic ⋮ Stochastic optimal therapy for enhanced immune response ⋮ Optimal treatment strategies derived from a HIV model with drug-resistant mutants ⋮ Optimal control of zika virus infection by vector elimination, vector-to-human and human-to-human contact reduction ⋮ Transmission dynamics and optimal control of measles epidemics ⋮ Optimal control of infectious disease: information-induced vaccination and limited treatment ⋮ A computational study of HSV-2 with poor treatment adherence ⋮ Within-host virus models with periodic antiviral therapy ⋮ Models of disease vector control: when can aggressive initial intervention lower long-term cost? ⋮ Can the viral reservoir of latently infected \(CD4^{+}\) T cells be eradicated with antiretroviral HIV drugs? ⋮ Optimal control of Aedes aegypti mosquitoes by the sterile insect technique and insecticide ⋮ Global stability analysis and control of leptospirosis ⋮ Toward a model-free feedback control synthesis for treating acute inflammation ⋮ Dynamics of a stochastic cell-to-cell HIV-1 model with distributed delay ⋮ Threshold dynamics and optimal control of an age-structured giving up smoking model ⋮ Viable control of an epidemiological model ⋮ Dynamical analysis of chemotherapy models with time-dependent infusion ⋮ Mathematical model and intervention strategies for mitigating tuberculosis in the Philippines ⋮ Optimal control analysis of malaria-schistosomiasis co-infection dynamics ⋮ A general framework for multi-compartmental analysis of drug chemotherapy dynamics in human immunodeficiency virus type-1 infected individuals ⋮ Optimal control for HIV treatment ⋮ Optimal control in HIV chemotherapy with termination viral load and latent reservoir ⋮ Optimal control strategies for a new ecosystem governed by reaction-diffusion equations ⋮ Optimal control of a delayed HIV infection model with immune response using an efficient numerical method ⋮ Modeling and control for HIV/AIDS transmission in China based on data from 2004 to 2016 ⋮ A fractional calculus model for HIV dynamics: real data, parameter estimation and computational strategies ⋮ Dynamical behaviour of HIV infection with the influence of variable source term through Galerkin method ⋮ Pulse HIV vaccination: feasibility for virus eradication and optimal vaccination schedule
This page was built for publication: Optimal control of the chemotherapy of HIV
